Back to Journals » Therapeutics and Clinical Risk Management » Volume 9

Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations

Total article views   HTML views PDF downloads Totals
9,917 Dovepress* 7,952+ 1,941 9,893
PubMed Central* 1,965 422 2,387
Totals 9,917 2,363 12,280
*Since 25 November 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed Central and Google Scholar